Original articles
Mitochondrial DNA Mutations Are Associated with Both Decreased Insulin Secretion and Advanced Microvascular Complications in Japanese Diabetic Subjects

https://doi.org/10.1016/S1056-8727(99)00060-4Get rights and content

Abstract

To assess the roles of various mitochondrial (Mt) DNA mutations in diabetic and nondiabetic subjects, we screened Mt DNAs at the 3243 base pair (bp) and its adjacent portion in unrelated Japanese diabetic and nondiabetic subjects. Furthermore, to clarify the clinical features of diabetic subjects harboring a Mt DNA mutation, we evaluated the ability of insulin secretion and microvascular complications in diabetic subjects. Five hundred thirty-seven diabetic patients and 612 unrelated nondiabetic subjects were recruited into this study. In Mt DNA analyses, Mt DNA was isolated from peripheral leukocytes of the subjects, and then an Mt DNA fragment surrounding the tRNALeu(UUR) site was amplified by the polymerase chain reaction (PCR) using two sets of primers. These fragments were further digested with three kinds of restriction endonucleases and were subjected to agarose gel electrophoresis. When a mutation was present, Mt DNA fragments were directly sequenced with an autosequencer. Baseline characteristics in all subjects were examined, and microvascular complications and insulin secretory capacity in diabetic subjects were newly evaluated. Eight kinds of Mt DNA mutations, which were point mutations, were found in 74 subjects. Each affected subject had only one mutation in the Mt DNA examined. Among them, the mutations at np 3316, 3394, 3593, and 3391 were accompanied by amino acid replacement. Thirty-eight diabetic patients were affected (7.1%), including two subjects with a point mutation at np 3243, and 26 nondiabetic subjects were affected (4.2%). Thus, there was a higher prevalence in diabetic subjects than in nondiabetic subjects. There was no significant difference in the prevalence of maternally inherited diabetes between these two groups. The mean level of urinary C-peptide excretion was lower in diabetic subjects with an Mt DNA mutation (DM+) than in those without it (DM−). Although the prevalence of hypertension in DM+ was higher than that in DM−, diabetic retinopathy and nephropathy in DM+ were problematic, in comparison with those in DM−, when statistical corrections were performed for the effect of hypertension. Furthermore, a strategy based on logistic regression analysis revealed that advanced retinopathy and decreased urinary C-peptide excretion in all diabetic subjects studied were strongly related to the presence of Mt DNA mutation. Our results suggest that Mt DNA mutations in Japanese diabetic subjects are related to the development of diabetes, and also that these mutations are associated with not only a decrease in insulin secretion but also advanced diabetic microvascular complications.

Introduction

Many kinds of mutations and deletions in mitochondrial (Mt) DNA have been reported to be associated with the development of diabetes mellitus, in concert with other genetic factors and/or environmental factors.1−4 Among them, tRNALue(UUR) and its adjacent region within the Mt genome are linked to high susceptibility to diabetes mellitus.2 A point mutation at 3243 base pair (bp) in the Mt tRNALue(UUR) gene is commonly referred to as MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes), and it has been recognized as a causative factor in a new clinical entity: maternally inherited diabetes and deafness (MIDD).5, 6 Mt dysfunction through the involvement of Mt oxidative phosphorylation may lead to impairment of glucose-induced insulin secretion from pancreatic β cells in subjects harboring these mutations.2, 3, 7 The clinical phenotypes of diabetes mellitus with these mutations are generally heterogeneous.5, 8 However, there is little information about the degree of microvascular complications in diabetic subjects with an Mt DNA mutation.

To assess the roles of various Mt DNA mutations in diabetic and nondiabetic subjects, we screened for Mt DNAs at the 3243 bp and its adjacent portion in Japanese unrelated 537 diabetic and 612 nondiabetic subjects. Furthermore, to clarify the clinical features of diabetic subjects harboring an Mt DNA mutation, we evaluated the ability of insulin secretion and microvascular complications in diabetic subjects.

Section snippets

Subjects

The Japanese subjects studied were 537 diabetic subjects (299 men, 238 women; including 24 type I diabetes, 12 men and 12 women) and 612 nondiabetic subjects (197 men, 415 women) who were inpatients or outpatients of Kanazawa Medical University Hospital. Nondiabetic subjects were patients who were diagnosed as having mild hypertension, hyperlipidemia, or thyroid disease, and were under treatment. Informed consent was obtained from each participant. Type II diabetes was diagnosed according to

Clinical Characteristics of Diabetic and Nondiabetic Subjects Studied

Clinical characteristics of the diabetic and nondiabetic subjects studied are shown in Table 1. There were significant differences in age, gender, and HbA1c between diabetic and nondiabetic subjects. The median (range) duration of diabetes in the diabetic subjects was 10 (0–42) years. BMI was similar between the two groups.

Mt DNA Analysis in Diabetic and Nondiabetic Subjects Studied

As shown in Table 2, eight kinds of Mt DNA point mutations were identified, all of which were single mutations. Each affected subject had only one mutation in the Mt DNA

Discussion

In this study, we demonstrated that the prevalence of Mt DNA mutation was higher in unrelated Japanese diabetic subjects than in nondiabetic subjects, showing that mutated Mt DNA may be linked to the development of diabetes. Furthermore, we showed that the prevalence of maternally inherited diabetes in diabetic subjects, even with Mt DNA mutation, was low, and that microvascular complications in diabetic subjects with an Mt DNA mutation were more pronounced than those in diabetic subjects

Acknowledgements

This work was in part supported by a Grant for Project Research from Kanazawa Medical University (P98-2).

References (31)

  • J. van den Ouweland et al.

    Maternally inherited diabetes and deafness (MIDD)A distinct subtype of diabetes associated with a mitochondrial tRNALue(UUR) gene point mutation

    Muscle Nerve Suppl

    (1995)
  • A. Sener et al.

    Stimulation by D-glucose of mitochondrial oxidative events in ilet cells

    Biochem J

    (1987)
  • T. Kadowaki et al.

    A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA

    N Engl J Med

    (1994)
  • World Health Organization: WHO Expert Committee on Diabetes Mellitus. Scond Report. Geneva, World Health Organization,...
  • Report of the Expert Committee on the Diagnosis and Classification of Diabetes mellitus

    Diabetes Care

    (1997)
  • Cited by (19)

    • The clinical characteristics of patients with mitochondrial tRNA Leu(UUR)m.3243A > G mutation: Compared with type 1 diabetes and early onset type 2 diabetes

      2017, Journal of Diabetes and its Complications
      Citation Excerpt :

      It was reported that human populations can be divided into several mtDNA haplogroups on the basis of specific nucleotide polymorphisms, and some studies have pointed out the possible impact of haplogroups on mitochondrial physiology.32,33 Thus, mtDNA haplogroups might be the possible reason for the difference between Western and East Asian populations.3 Previous studies also demonstrated that macular pattern dystrophy might protect against the development of diabetic retinopathy through a reduction in retinal metabolism and a decrease in oxygen consumption in the retina.10,16

    • Usefulness of postmortem biochemistry in identification of ketosis: Diagnosis of ketoacidosis at the onset of autoimmune type 1 diabetes in an autopsy case with cold exposure and malnutrition

      2016, Legal Medicine
      Citation Excerpt :

      It is thought that she was placed under low temperature exposure as for this result [25]. The mitochondrial (mt) DNA 3243 mutation [26] was not detected in the whole blood. No blood alcohol was detected in several body fluids.

    • Novel mutations found in mitochondrial diabetes in Chinese Han population

      2007, Diabetes Research and Clinical Practice
      Citation Excerpt :

      For detection of T3200C and C3206T mutations, AS-PCR was carried out as described previously [13]. To identify the other mutant loci, six primer pairs were used to amplify the target fragments, which of eight were from literatures [14,15]; the others were designed by Primer premier 5.0 and Oligo 6.70. The sequences were as follows: 1657F 5′-CTTGACCGCTCTGAGCTAAAC-3′, 2216R 5′-TGTTGAG CTTGAACGCTTTC-3′ [14]; 3160F 5′-AGCGCCTTCCCCCGTAAATGA-3′, 3755 R 5′-AGAA TGATGGCTAGGGTGACTTC-3′ [15]; 4048F 5′-GACGCACTCTCCCCTGAACTCC-3′, 4365R 5′-GGATTCTCAGGGATGGGTTCG-3′; 4797F 5′-CCCTTTCACTTCTGAGTCCCAG-3′ [14], 5549R 5′-CTTTGAAGGCTCTTGGTCTGTAT-3′; 8164F 5′-CGGTCAATGCTCTGAAATCTG TG-3′, 8669R 5′-CATTGTTGGGTGGTGATTAGTCG-3′ [14]; 11901F 5′-TGCTAGTAACCA CGTTCTCCTG-3′ [14], 12764R 5′-CCGATGAACAGTTGGAATAGG-3′.

    • The Epidemiology of Diabetic Retinopathy

      2005, Retina: Fourth Edition
    View all citing articles on Scopus
    View full text